Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)

NCT01101451 is registered in ClinicalTrials.gov with GOG Foundation as lead sponsor.

NCT NCT01101451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01101451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Lead sponsor
GOG Foundation
Phase
Phase 3
Overall status
Completed
Start date
April 12, 2010
Completion date
April 2, 2024
Enrollment
340 (actual)
Sites
719

Conditions

As the registry lists them; a condition with its own page is linked.

cervical adenocarcinoma, cervical adenosquamous carcinoma, cervical squamous cell carcinoma, not otherwise specified, stage i cervical cancer ajcc v6 and v7, stage ia cervical cancer ajcc v6 and v7, stage ib cervical cancer ajcc v6 and v7, stage iia cervical cancer ajcc v7